DrugPatentWatch Database Preview

NYMALIZE Drug Profile

« Back to Dashboard

When do Nymalize patents expire, and when can generic versions of Nymalize launch?

Nymalize is a drug marketed by Arbor Pharms Llc and is included in one NDA.

The generic ingredient in NYMALIZE is nimodipine. There are seven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the nimodipine profile page.

Summary for NYMALIZE

US Patents:	0
Applicants:	1
NDAs:	1
Suppliers / Packagers:	1
Bulk Api Vendors:	84
Patent Applications:	4,457
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for NYMALIZE
DailyMed Link:	NYMALIZE at DailyMed

Pharmacology for NYMALIZE

Drug Class	Dihydropyridine Calcium Channel Blocker
Mechanism of Action	Calcium Channel Antagonists

Medical Subject Heading (MeSH) Categories for NYMALIZE

Antihypertensive Agents

Calcium Channel Blockers

Vasodilator Agents

Synonyms for NYMALIZE

085N594

1-methylethyl 2-(methyloxy)ethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

1,?4-?DIHYDRO-?2,?6-?DIMETHYL-?4-?(3-?NITROPHENYL)-?3-?(2-?METHOXYETHYL) 5-?(1-?METHYLETHYL) ESTER,? 3,?5-?PYRIDINEDICARBOXYLIC ACID

1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid isopropyl 2-methoxyethyl ester

1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinecarboxylic acid 2-methoxyethyl 1-methylethyl ester

1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid

1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methoxyethyl 1-methylethyl ester

1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methoxyethyl 1-methylethyl ester; Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate

1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methyloxyethyl 1-methylethyl ester

1,4-Dihydro-2,6-dimethyl-4-(3&prime

1,4-Dihydro-2,6-dimethyl-4-(3′-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methoxyethyl-1-methylethyl Ester

2-Methoxyethyl 1-Methylethyl 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate

2-methoxyethyl propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

2-Methoxyethyl-1-methylethyl ester

2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester

3-(2-methoxyethyl) 5-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

3-Isopropyl 5-(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydro-3,5-pyridinedicarboxylate #

3-isopropyl 5-(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

3-O-(2-methoxyethyl) 5-O-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

3,5-pyridinecarboxylic acid 2-methoxyethyl 1-methylethyl ester

3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-methoxyethyl 1-methylethyl ester

3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-,2-methoxyethyl 1-methylethyl ester

3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl), 2-methoxyethyl 1-methylethyl ester

4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-N,N-dimethyl-2,2-diphenyl-butanamide

66085-59-4

AB00053314_05

AB00053314_06

AB00053314-03

AB00053314-04

AB0012346

AB00513963

AB1009471

AC-8484

AC1L1IAS

AC1Q4G7S

ACT02628

Admon

AK163644

AKOS005174934

AKOS015852459

ALBB-015317

Almirall Brand of Nimodipine

Alpharma Brand of Nimodipine

AN-7970

Andromaco Brand of Nimodipine

BAY e 9736

Bay-E 9736

Bay-e-9736

Bayer Brand of Nimodipine

Bayvit Brand of Nimodipine

BBL028286

BDBM50101971

Bio-0178

Bio1_000118

Bio1_000607

Bio1_001096

Bio2_000117

Bio2_000597

BPBio1_000876

Brainal

BRD-8407

BRD-A58048407-001-06-3

BRD8407

BRN 0459792

BSPBio_000796

BSPBio_001397

BSPBio_002412

C07267

C21H26N2O7

Calnit

Cantabria Brand of Nimodipine

CAS-66085-59-4

CBiol_001832

CCG-101085

CCG-39340

CHEBI:7575

CHEMBL3197349

CPD002530605

CS-2253

CTK8J9033

D00438

D0XN1F

DB00393

DivK1c_006812

DR002557

DRG-0139

DSSTox_CID_3370

DSSTox_GSID_23370

DSSTox_RID_76998

DTXSID5023370

EG-1961

EINECS 266-127-0

Elan Brand of Nimodipine

Esteve Brand of Nimodipine

EU-0100891

FT-0082761

FT-0602600

GTPL2523

HE229490

Hexal Brand of Nimodipine

HMS1361F19

HMS1570H18

HMS1791F19

HMS1922E04

HMS1989F19

HMS2052M05

HMS2089H13

HMS2093G11

HMS2097H18

HMS2234B05

HMS3262D04

HMS3266O22

HMS3369G07

HMS3394M05

HMS3402F19

HMS3657I03

HY-B0265

I06-0230

IDI1_033867

isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate

isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate

Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate

isopropyl 2-methoxyethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

KBio1_001756

KBio2_000117

KBio2_002403

KBio2_002685

KBio2_004971

KBio2_005253

KBio2_007539

KBio3_000233

KBio3_000234

KBio3_001632

KBioGR_000117

KBioGR_001262

KBioSS_000117

KBioSS_002408

Kenesil

KS-1304

Lopac0_000891

LP00891

LS-131292

MCULE-4717687158

methylethyl 5-[(2-methoxyethyl)oxycarbonyl]-2,6-dimethyl-4-(3-nitrophenyl)-1,4 -dihydropyridine-3-carboxylate

MFCD00153848

MLS000069381

MLS000863294

MLS001076550

MLS001424155

MLS002154061

MLS002172461

MLS003899190

Modus

MolPort-001-840-190

N-149

N0896

NC00335

NCGC00015714-04

NCGC00015714-05

NCGC00015714-06

NCGC00015714-07

NCGC00015714-08

NCGC00015714-09

NCGC00015714-10

NCGC00015714-11

NCGC00015714-12

NCGC00015714-13

NCGC00015714-16

NCGC00021456-02

NCGC00024675-02

NCGC00024675-03

NCGC00024675-04

NCGC00024675-05

NCGC00024675-06

NCGC00024675-07

NCGC00024675-08

NCGC00024675-09

NCGC00261576-01

nemotan

Nimodipin Hexal

Nimodipin ISIS

Nimodipin-ISIS

nimodipine

Nimodipine (Nimotop)

Nimodipine (USAN/INN)

Nimodipine [USAN:BAN:INN]

Nimodipine [USAN:USP:INN:BAN]

Nimodipine for peak identification, EuropePharmacopoeia (EP) Reference Standard

Nimodipine, British Pharmacopoeia (BP) Reference Standard

Nimodipine, European Pharmacopoeia (EP) Reference Standard

Nimodipine, pharmaceutical secondary standard; traceable to USP, PhEur and BP

Nimodipine, United States Pharmacopeia (USP) Reference Standard

NimodipinISIS

Nimodipino

Nimodipino [INN-Spanish]

Nimodipino Bayvit

Nimodipinum

Nimodipinum [INN-Latin]

NimoGel

Nimotop

NIMOTOP (TN)

Nimotop, Nimodipine

Nimotop(TM)

Nimotop|||Admon|||BAY-e 9736

NimoVent

NSC-758476

NSC758476

Nymalize (TN)

O5-(2-methoxyethyl) O3-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

O5-isopropyl O3-(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

Opera_ID_14

Periplum

Periplum, Nimotop, BRN 0459792, DRG-0139

Pharmakon1600-01503600

Prestwick0_000918

Prestwick1_000918

Prestwick2_000918

Prestwick3_000918

PubChem16211

R2304

Remontal

s1747

SAM001246890

SBI-0050866.P003

SC-17122

SCHEMBL34041

SMR000058300

SMR002530605

SPBio_001464

SPBio_002985

SpecPlus_000716

Spectrum_001880

SPECTRUM1503600

Spectrum2_001562

Spectrum3_000766

Spectrum4_000791

Spectrum5_001687

SR-01000075335

SR-01000075335-2

ST082783

STK642934

Tox21_110202

Tox21_110202_1

Tox21_500891

UIAGMCDKSXEBJQ-UHFFFAOYSA-N

Vita Brand of Nimodipine

US Patents and Regulatory Information for NYMALIZE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Arbor Pharms Llc	NYMALIZE	nimodipine	SOLUTION;ORAL	203340-001	May 10, 2013		RX	Yes	Yes